Company / SG&A per Share
Exelixis SG&A per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$1.84
FY2025
5-year range
$0.73 / $1.84
FY2021-FY2025
Trend
+13.3%
vs FY2024
Sector context
#85 of 210
Health Care
What the data says
At $1.84, Exelixis's sg&a per share ranks #126 of 210 in the Health Care sector. SG&A per Share has fluctuated over the past 10 years, ranging from $0.39 in FY2018 to $1.84 in FY2025.
Based on SEC 10-K filings.
1.84 in FY2025 with a 5-year CAGR of +13.9%.
Increased from $1.68 to $1.84 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +26.0%
- 5-Year CAGR
- +13.9%
- 10-Year CAGR
- -
Sector benchmark
#126 of 210 in Health CareTop 60% of 210This company $1.84 Sector average $29.50
▼
-93.8% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 13.3% year-over-year.
- Ranks #85 out of 210 companies in the Health Care sector.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 3.33 (safe zone, above 2.9 threshold)
- Strong profit margin: 29.6%
- High earnings quality (cash-backed earnings)
- Strong return on equity: 31.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.84 | +13.3% |
| FY2024 | $1.63 | -3.0% |
| FY2023 | $1.68 | +82.1% |
| FY2022 | $0.92 | +25.6% |
| FY2021 | $0.73 | -23.9% |
| FY2020 | $0.96 | +26.4% |
| FY2019 | $0.76 | +94.1% |
| FY2018 | $0.39 | -28.7% |
| FY2017 | $0.55 | +7.9% |
| FY2016 | $0.51 | +74.2% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026